Popular on TelAve
- Cover Story about Matthew Cossolotto – Author of Harness Your PromisePower -- Published in July 2026 Enterprise World Magazine - 367
- Lineus Medical Signs Partnership Agreement with DIMA MedTech to Support Expansion into Italy - 365
- Studica Robotics Supports Robotics Training Camp for WorldSkills Shanghai 2026 - 346
- WhereTu Launches to Help Americans Build Successful Lives Abroad - 323
- Mr. Hospital Bed Helps Home Care Buyers Find the Right Hospital Bed - 280
- Martin A. Sumichrast Joins Hawkeye Systems, Inc. as Chairman of the Board - 113
- From the Racetrack to the Boardroom: Aston Martin and Aramco Formula One Partnership Accelerates Circle8 Group: (N A S D A Q: CIRC) - 110
- NextBoat's AI-Powered Marine Marketplace Gains Momentum as Record Growth Signals an Inflection Point for Investors (N Y S E American: NXB)
- Northeast Airlines Launches New Asset Management Group
- Telecom Equipment Group Launches AI-Ready Modular Infrastructure Solution for Next-Gen Networks
Lineus Medical Elevates Leadership to Accelerate Growth After Breakthrough Clinical Results
TelAve News/10903377
FAYETTEVILLE, Ark. - TelAve -- Lineus Medical, maker of SafeBreak Vascular, has seen breakthrough clinical results at multiple hospital systems across the U.S. that validate the clinical and health-economic value proposition for SafeBreak, the first breakaway device for IV lines.
The cumulative data, cultivated through evidence-based medicine and demonstrated across tens of thousands of patients, is convincing and has clearly demonstrated SafeBreak's value, use, and adoption as a true standard of care. Based on the clinical success seen to date, additional capital has been raised to accelerate commercial efforts in the U.S., Europe, Latin America, and Asia.
To support this growth, the company has promoted Larry Hayes to President and Chief Commercial Officer. In his expanded role, Larry will oversee the company's marketing, sales, manufacturing, and human resources functions, consolidating operational leadership under a single point of accountability as Lineus scales its commercial operations.
More on TelAve News
"I'm honored to take on this role at such a pivotal moment for Lineus Medical. We have built tremendous momentum over the past year. Stepping into this role, alongside my commercial responsibilities, gives me a broader hand in how we scale our growth long-term. We're not changing direction, we're accelerating it," said Hayes.
"This new leadership structure, alongside recent investments, reflects the confidence we have in Lineus Medical's trajectory. Larry has been instrumental in establishing Lineus' Clinical Evidence Program through the Breakaway Impact Registry, a key to the company's commercial success. This expanded role positions Larry to help lead our next stage of growth," said Jonathon Fite, Chairman of the Board.
CEO and co-founder, Vance Clement, will continue to lead the company with a renewed passion on next generation vascular access solutions. "I am excited to focus on the long-term future of Lineus Medical and the scientific advancement of our intellectual property and product portfolio," said Vance Clement.
More on TelAve News
Additionally, Lineus announces the appointment of Pravin Raj to its Board of Directors. Mr. Raj's services and technology background to help organizations scale will complement the company's near-term commercialization and long-term portfolio development goals.
SafeBreak Vascular is a breakaway device for IV lines that separates when a damaging force is applied to IV lines, removing the damaging forces and protecting the patient's IV line. When separation occurs, valves on both ends of the device close to prevent medication spills from the pump, and blood loss from the patient. SafeBreak has been shown to reduce mechanical IV complications in a range of 44%-91%.1 The device is FDA-cleared for use across all vascular lines, CE Mark certified for use across the European Union, and is distributed across markets spanning more than three continents.
About Lineus Medical
Lineus Medical is the developer of SafeBreak Vascular, a breakaway technology proven to reduce IV complications.1 Our mission is to remove the pains associated with medical lines. More information about Lineus Medical can be found at www.lineusmed.com. Follow Lineus Medical for more on LinkedIn, Facebook, and Instagram.
Reference:
1. Data on File.
The cumulative data, cultivated through evidence-based medicine and demonstrated across tens of thousands of patients, is convincing and has clearly demonstrated SafeBreak's value, use, and adoption as a true standard of care. Based on the clinical success seen to date, additional capital has been raised to accelerate commercial efforts in the U.S., Europe, Latin America, and Asia.
To support this growth, the company has promoted Larry Hayes to President and Chief Commercial Officer. In his expanded role, Larry will oversee the company's marketing, sales, manufacturing, and human resources functions, consolidating operational leadership under a single point of accountability as Lineus scales its commercial operations.
More on TelAve News
- UK Financial Ltd Makes History: Chainlink CRE Circulating Supply Verification Goes Live Across Its Complete Ecosystem Of Nine Exchange-Traded Tokens
- International Rights Groups Raise Alarm Over Freedom of Religion and Expression in South Korea
- The City's Most Elegant Open-Air Dinner Party Returns September 12, 2026
- FDA Clears Major Regulatory Hurdle as Preservative-Free Ketamine Program Moves Within Reach of Commercialization: NRx Pharmaceuticals: (NAS DAQ: NRXP)
- Autonomous Robotics Platform Expansion as Public Market Debut is Very Close: MBody AI Corp. (N A S D A Q: MBAI)
"I'm honored to take on this role at such a pivotal moment for Lineus Medical. We have built tremendous momentum over the past year. Stepping into this role, alongside my commercial responsibilities, gives me a broader hand in how we scale our growth long-term. We're not changing direction, we're accelerating it," said Hayes.
"This new leadership structure, alongside recent investments, reflects the confidence we have in Lineus Medical's trajectory. Larry has been instrumental in establishing Lineus' Clinical Evidence Program through the Breakaway Impact Registry, a key to the company's commercial success. This expanded role positions Larry to help lead our next stage of growth," said Jonathon Fite, Chairman of the Board.
CEO and co-founder, Vance Clement, will continue to lead the company with a renewed passion on next generation vascular access solutions. "I am excited to focus on the long-term future of Lineus Medical and the scientific advancement of our intellectual property and product portfolio," said Vance Clement.
More on TelAve News
- Loud! OOH calls for prize draw advertising standards as £1.3bn category moves outdoors
- Black Ribbon Productions Launches With Fearless 2026 Horror Slate
- Actor Dominic Pace Returns to Television and Film
- Opteamix welcomes Girish Ramachandra to its leadership team as Senior Vice President of Client Services
- Silicon Box Ships 500M Units at High Yield, Expands Production Capacity for Panel-Level Packaging
Additionally, Lineus announces the appointment of Pravin Raj to its Board of Directors. Mr. Raj's services and technology background to help organizations scale will complement the company's near-term commercialization and long-term portfolio development goals.
SafeBreak Vascular is a breakaway device for IV lines that separates when a damaging force is applied to IV lines, removing the damaging forces and protecting the patient's IV line. When separation occurs, valves on both ends of the device close to prevent medication spills from the pump, and blood loss from the patient. SafeBreak has been shown to reduce mechanical IV complications in a range of 44%-91%.1 The device is FDA-cleared for use across all vascular lines, CE Mark certified for use across the European Union, and is distributed across markets spanning more than three continents.
About Lineus Medical
Lineus Medical is the developer of SafeBreak Vascular, a breakaway technology proven to reduce IV complications.1 Our mission is to remove the pains associated with medical lines. More information about Lineus Medical can be found at www.lineusmed.com. Follow Lineus Medical for more on LinkedIn, Facebook, and Instagram.
Reference:
1. Data on File.
Source: Lineus Medical
0 Comments
Latest on TelAve News
- HER Patio Productions celebrates one-year Anniversary of "Say Grace"
- Working Musicians Academy Partners with Black Dog Music Partners to Give Musicians Independent, Income-Producing Careers
- Omnitronics launches Ecosystem Health Dashboard to enable proactive monitoring across dispatch environments
- New Research Identifies "The Great Junk Transfer": 49% of Americans Would Rather Inherit Nothing Than Sort Through a Relative's Belongings
- Minus K Technology launches it Educational Giveaway for Universities and Colleges in the USA
- UK Financial Ltd Verifies Maya Preferred PRA Circulating Supply, Proving Its Eight-Year Promise of Under 1M Tokens After Chainlink Labs Agreement
- Anamorphic 3D Only Works on Fixed Screens. Loud! OOH Put It on a Moving Ad Van for Flood Re
- From DJ Booths to Disney: Orlando Author Ryan Tiffin Launches "Chasing Magic"
- FDA Food Recall Notices After Outbreak Linked to 98 Hospitalizations: Practical Tips for Safer Grocery Shopping
- The 'Tax Squeeze': Betsson's Record Quarter Previews the Economics of Finland's 2027 Casino Market
- ImagineX Acquires Payteros to Strengthen Digital Transformation Capabilities
- From Pizza to Playlists: Marty The Pizza Guy Delivers Three Delicious New Songs
- Salestrics Introduces PraiseEngine: The AI-Native Review Engine Built to Fix Social Proof
- Phinge Notifies Parties in Apple v. Liu it is Exploring Amicus Curiae Submission Regarding its Foundational App-less & Hardware Verified Technologies
- K2 Integrity Names Michael Kallabat Global Head of Investigations and Disputes
- Socialhose Eyes Southeast Asia and Rejects the Copy-Paste Expansion Playbook
- $40 Billion Global Market Value by 2030 Projected in Unmanned Aerial Vehicle or Other Drone Technology Sector, Growing at 9.2% Compound Annual Growth
- Mobile & IoT connectivity specialist Cellhire strengthens channel team with four new appointments
- $620 Million in Recent Government Contract Awards with More Than $1.2 Billion in Annualized Revenue: Circle8 Group (N A S D A Q: CIRC)
- Lewis County Hydrogen Alliance Launches Phase 1 Work to Turn Forest Residuals into Fuel-Grade Hydrogen and Dispatchable Clean Power


